November 20 - 21, 2020

 
Registration Deadline: February 6, 2021
Virtual Platform Close Date: February 22, 2021

CME/CE Credit

THIS CONFERENCE IS FOR YOU

Dermatologists • Family Physicians • Internists • Physician Assistants • Nurse Practitioners • Nurses • Residents

 

Learning Objectives

After completing this live activity, participants should be better able to:

Psoriasis

  • Design treatment options that incorporate biologic therapies into the management of appropriately selected patients with psoriasis.
  • Describe the pathophysiology of psoriasis and its co-morbidities.
  • Diagnose and treat patients with psoriasis appropriately based on current guidelines.

Atopic Dermatitis

  • Incorporate strategies for use of new therapies aimed at blocking the inflammatory mediators of atopic dermatitis.
  • Review topical treatment for atopic dermatitis.
  • Design evidence-based, guideline-driven treatment strategies for patients with atopic dermatitis based on severity with the goal of clear or almost clear skin.

Rosacea

  • Discuss appropriate treatment strategies for rosacea based on individual signs and symptoms as well as knowledge of indications, efficacy, and risks of available and emerging rosacea therapies.

Acne

  • Design a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and non-pharmacologic strategies.
  • Discuss the clinical relevance of the most recent research on the etiologies and therapy of acne vulgaris.

Photosensitivity Disorders

  • Identify and treat patients with photosensitivity disorders.

Keloids and Scars

  • Describe the pathophysiology of keloids.
  • Identify characteristics of keloids and first-line treatment options.

Management of Melanoma and Dysplastic Nevi

  • Distinguish malignant from non-malignant suspicious neoplasms.
  • Discuss available treatment strategies for melanoma at various stages of its progression.

Aesthetic Dermatology

  • List the benefits and risks of current agents and techniques commonly used in aesthetic and procedural dermatology.
  • Select filler agents suitable for use in treating different facial areas.
  • Identify a nonsurgical treatment strategy, including potential use of neuromodulators, to address patient concerns about facial aging.
 
Accreditation and Designation statements
 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
Postgraduate Institute for Medicine designates this continuing education activity for 13 contact hours (1.35 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - Live: UAN: JA4008162-9999-20-2260-L01-P
Type of Activity : Knowledge

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours. Pharmacotherapy contact hours for Advanced Practice Nurses will be designated on your certificate.

Continuing Physician Assistants Education

The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

MOC-D
The self-assessment program offered at the 21st Las Vegas Dermatology Symposium is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points. Please be sure to report completion of any self-assessment programs on your MOC-D table located in your ABD profile (www.abderm.org).

AAFP Credit
The AAFP has reviewed The 21st Annual Las Vegas Dermatology Seminar Featuring the Annual Psoriasis and Atopic Dermatitis Forums, a Medscape Live conference and deemed it acceptable for up to 13 Online Only, Live AAFP Prescribed credit. Term of Approval is from 11/20/2020 to 11/21/2020. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Follow Us

Jointly Provided By

In Association With